wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38164139-2350F9B6-0CAA-4602-8604-AB8459064DE5
Q38164139-2350F9B6-0CAA-4602-8604-AB8459064DE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38164139-2350F9B6-0CAA-4602-8604-AB8459064DE5
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application.
P2860
Q38164139-2350F9B6-0CAA-4602-8604-AB8459064DE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38164139-2350F9B6-0CAA-4602-8604-AB8459064DE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9016db19c90db46114744a0ab6ebd114f60509dc
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.